NCT05160922 2026-03-30Crizotinib Continuation Clinical StudyPfizerPhase 4 Active not recruiting27 enrolled
NCT01909934 2025-09-19Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell LymphomaTakedaPhase 4 Completed50 enrolled 22 charts